386 related articles for article (PubMed ID: 27624381)
21. Autism spectrum disorders and their treatment with psychotropic medications in a nationally representative outpatient sample: 1994-2009.
Kamimura-Nishimura K; Froehlich T; Chirdkiatgumchai V; Adams R; Fredstrom B; Manning P
Ann Epidemiol; 2017 Jul; 27(7):448-453.e1. PubMed ID: 28789776
[TBL] [Abstract][Full Text] [Related]
22. Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: a systematic review.
Muskens JB; Velders FP; Staal WG
Eur Child Adolesc Psychiatry; 2017 Sep; 26(9):1093-1103. PubMed ID: 28674760
[TBL] [Abstract][Full Text] [Related]
23. Child, parent, and service predictors of psychotropic polypharmacy among adolescents and young adults with an autism spectrum disorder.
Lake JK; Weiss JA; Dergal J; Lunsky Y
J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):486-93. PubMed ID: 25329798
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.
Murray ML; Hsia Y; Glaser K; Simonoff E; Murphy DG; Asherson PJ; Eklund H; Wong IC
Psychopharmacology (Berl); 2014 Mar; 231(6):1011-21. PubMed ID: 23681164
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic medication use among children with autism spectrum disorders within the Simons Simplex Collection: are core features of autism spectrum disorder related?
Mire SS; Nowell KP; Kubiszyn T; Goin-Kochel RP
Autism; 2014 Nov; 18(8):933-42. PubMed ID: 24031086
[TBL] [Abstract][Full Text] [Related]
27. Psychotropic medication use among adolescents and young adults with an autism spectrum disorder: parent views about medication use and healthcare services.
Lake JK; Vogan V; Sawyer A; Weiss JA; Lunsky Y
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):260-8. PubMed ID: 25803636
[TBL] [Abstract][Full Text] [Related]
28. Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients.
Araz Altay M; Bozatlı L; Demirci Şipka B; Görker I
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108992
[No Abstract] [Full Text] [Related]
29. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
30. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
31. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
[TBL] [Abstract][Full Text] [Related]
32. Patient-Level Medication Regimen Complexity in an Adolescent and Adult Population with Autism Spectrum Disorders.
Barnette DJ; Hanks C; Li W; Porter K
Pharmacotherapy; 2019 Jun; 39(6):636-644. PubMed ID: 30508268
[TBL] [Abstract][Full Text] [Related]
33. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
Girand HL; Litkowiec S; Sohn M
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
[TBL] [Abstract][Full Text] [Related]
34. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
[TBL] [Abstract][Full Text] [Related]
35. Increase in Psychoactive Drug Prescriptions in the Years Following Autism Spectrum Diagnosis: A Population-Based Cohort Study.
Croteau C; Mottron L; Presse N; Tarride JE; Dorais M; Perreault S
J Popul Ther Clin Pharmacol; 2017 Aug; 24(3):e19-e32. PubMed ID: 28873291
[TBL] [Abstract][Full Text] [Related]
36. Characteristics Associated with Drug Prescription and Compliance Among Young Children with Autism Spectrum Disorder.
Meiri G; Azoulay H; Menashe I
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):232-237. PubMed ID: 29266976
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic Medication Use by Children with Autism Served in Publicly Funded Mental Health Settings.
Caplan B; Chlebowski C; May G; Baker-Ericzén MJ; Connor W; Brookman-Frazee L
J Dev Behav Pediatr; 2022 Jun-Jul 01; 43(5):252-261. PubMed ID: 34855690
[TBL] [Abstract][Full Text] [Related]
38. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
39. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
40. Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome.
Dominick KC; Andrews HF; Kaufmann WE; Berry-Kravis E; Erickson CA
J Child Adolesc Psychopharmacol; 2021 Dec; 31(10):659-669. PubMed ID: 34818076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
